adj ep excl restructur amort
world lead provid diagnost test inform servic
revenu in-lin ep beat street estim modestli think
revenu growth solid although myriad move part make
compar histor result difficult lab other
benefit tax reform also deal ramif
pama quest exclud excess tax benefit stock-bas
compens etb guidanc compani continu execut
 strategi give nice jump start result also make
continu progress retail/consum strategi cost contain effort
convers potenti reimburs headwind still somewhat mute top-
line growth keep us hold rate rais price target
revenu essenti in-lin consensu
estim
clinic test revenu increas y/i better forecast
come requisit volum increas
organ volum growth augment growth
quest enjoy particularli robust standpoint
deal announc skew toward close led acceler
contribut revenu revenu per requisit increas
consist recent quarter unit price headwind less bp
advers impact convers mix factor said bp
helper driven test-mix advanc diagnost nipt hcv
prescript drug monitor greater test per requisit
adjust ep grew year ago
estim match consensu adjust oper incom grew
light estim adjust oper margin
basic flat y/i forecast gross margin
flat sequenti bp forecast off-set
sg expens come bp estim
